Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272
Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272
In this episode of Acquisitions Anonymous, Michael and Heather discuss an investment opportunity in a genomic testing , specializing in...
Let us know if you enjoyed this episodeIn this episode of Acquisitions Anonymous, Michael and Heather discuss an investment opportunity in a genomic testing , specializing in DNA sequencing and genotyping for mice. Despite their initial unfamiliarity with the technical details, they recognize the company's significant role in pharmaceutical research. They are impressed by its financial performance, noting substantial growth in revenue and EBITDA, along with high margins. The conversation also...
Episode Transcript
More Episodes
Are Pickleball Clubs the New Fad or the Next Fitness Empire?
In this episode, the Acquisitions Anonymous crew breaks down a freshly listed $1.9M indoor pickleball club in Houston, debating whether it’s a sports goldmine or a post‑trend trap.
$4.4 M Diabetes Patch Brand: Hidden Gem or Hidden Trap?
In this episode of Acquisitions Anonymous, the hosts dig into a $4.4 M e‑commerce business in the diabetes sensor accessory space and debate whether its 41% net margin, Australian base, and licensing opportunity make it a smart buy—or a risky startup in disguise.
$4.2M Security Business… With $773K Revenue?!
In this episode the hosts critique a $4.28 million asking price for a Signal Security Franchise business in San Antonio earning ~$773K revenue—arguing it’s overpriced, under‑differentiated and risky.